Study of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness

Validation of Stroke Volume Variation and Pleth Variability Index as Predictors of Fluid Responsiveness in Patients Undergoing Robot Assisted Thyroidectomy

Appropriate indices to guide fluid therapy are essential for effective hemodynamic management during the perioperative period. Values derived from respiratory changes in arterial pressure waveform or plethysmographic waveform such as stroke volume variation and pleth variability index have been demonstrated to be able to predict fluid responsiveness in surgical or critically ill patients. Their ability to predict fluid responsiveness can be affected by factors that influence the arterial tone or the compliance of the respiratory system by position change. The aim of this prospective trial is to investigate the ability of stroke volume variation and pleth variability index to predict fluid responsiveness in the reverse trendelenberg position.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: So-young Yang, clinical assistant professor
  • Phone Number: 82-2-6299-3160
  • Email: didth79@hanmail.net

Study Contact Backup

  • Name: Yong-hun Jung, professor
  • Phone Number: 82-2-6299-2579
  • Email: jyh623@cau.ac.kr

Study Locations

      • Seoul, Korea, Republic of, 156-755
        • Recruiting
        • Chung-Ang University Hospital
        • Contact:
        • Principal Investigator:
          • So-young Yang, MD,PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age ≥ 20
  2. elective robot assisted thyroidectomy

Exclusion Criteria:

  1. arrhythmia
  2. BMI>30
  3. valvular heart disease
  4. pul hypertension
  5. peripheral artery occlusive disease
  6. lung disease
  7. right heart failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: stroke volume variation, pleth variability index

stroke volume variation: recorded using the FloTrac/Vigileo system (Edwards Lifesciences)

pleth variability index: recorded using the Masimo Radical-7 monitor (Masimo Corporation, Irvine, CA, USA)

HES 130/0.4 (VolulyteⓇ, Fresenius Kabi, Canada) 6ml/kg of ideal body weight loading

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
stroke volume variation
Time Frame: 5 minutes after volume replacement
5 minutes after volume replacement
pleth variability index
Time Frame: 5 minutes after volume replacement
5 minutes after volume replacement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

March 1, 2015

Study Registration Dates

First Submitted

April 22, 2014

First Submitted That Met QC Criteria

April 23, 2014

First Posted (Estimate)

April 24, 2014

Study Record Updates

Last Update Posted (Estimate)

April 24, 2014

Last Update Submitted That Met QC Criteria

April 23, 2014

Last Verified

April 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • Chung-Ang UH

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroidectomy

Clinical Trials on HES 130/0.4 (VolulyteⓇ, Fresenius Kabi, Canada)

3
Subscribe